Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
'Euphoria' Season 3 trailer includes Eric Dane's final appearance, Jacob Elordi and Sydney Sweeney at the altar and Zendaya's 'Breaking Bad' era - 2This professional Santa's dream of spreading holiday cheer fuels stroke recovery
- 3In vogue Sleepwear Patterns for 2024
- 4Visual communication Programming for Fledglings
- 5James Webb Space Telescope's mysterious 'little red dots' may be black holes in disguise
- Consumer experts: German petrol hikes rule won't bring down prices
- One of the best meteor showers of the year peaks at the worst possible time this week
- Eleven Creations And Developments That Steered History
- Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
- Common ADHD medication prescribed in childhood may protect against risk of psychosis
- Vote In favor of Your Favored Distributed computing Administration
- Ukraine: Russians abduct 50 Ukrainians from border village in Sumy
- Astronauts welcome arrival of new crewmates | On the International Space Station this week Nov. 24-28, 2025
- Savvy Watches: Which One Is Appropriate for You?
